If you're reading this and are concerned about your own or someone else's use of Melanotan II, there are a few key takeaways to consider
Should it still be the first-line agent, or have newer drug classes like GLP1 receptor agonists and SGLT2 inhibitors earned Read More GLP1s and Liver Disease: Rethinking MASLD Care Beyond Obesity and A1C Jan 26, 2026 Articles, Diabetes, Featured, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 2,682 views Nonalcoholic steatohepatitis (NASH) and metabolic dysfunctionassociated steatotic liver disease (MASLD) are rapidly becoming leading causes of chronic liver disease worldwide
A revolutionary, safe, and non-habit-forming medication class for lasting weight loss, currently the most effective on the market
To prevent the development of thiamine deficiency: 100 mg IV daily